ZYXI Logo

Zynex, Inc. (ZYXI) 

NASDAQ
Market Cap
$243.94M
Sector
Healthcare
Industry
Medical—Distribution
Rank in Sector
328 of 945
Rank in Industry
3 of 9

Largest Insider Buys in Sector

ZYXI Insider Trading Activity

ZYXI Median Price and Trade Amounts History Chart

About Zynex, Inc.

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Insider Activity of Zynex, Inc.

Over the last 12 months, insiders at Zynex, Inc. have bought $58,233 and sold $854,590 worth of Zynex, Inc. stock.

On average, over the past 5 years, insiders at Zynex, Inc. have bought $53,864 and sold $14.04M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Disbrow Joshua R. (director) — $116,466.

The last purchase of 7,000 shares for transaction amount of $58,233 was made by Disbrow Joshua R. (director) on 2024‑07‑29.

List of Insider Buy and Sell Transactions, Zynex, Inc.

2025-02-03SaleCHIEF FINANCIAL OFFICER
10,000
0.0308%
$7.68$76,800+3.43%
2025-01-02SaleCHIEF FINANCIAL OFFICER
10,000
0.0316%
$7.88$78,800+2.94%
2024-12-02SaleCHIEF FINANCIAL OFFICER
10,000
0.0308%
$8.08$80,800-1.46%
2024-11-14SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0064%
$8.09$16,1800.00%
2024-11-13SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0065%
$8.37$16,7400.00%
2024-11-12SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0068%
$9.24$18,480-5.13%
2024-11-11SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0062%
$9.09$18,180-12.58%
2024-11-08SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0061%
$8.77$17,540-9.77%
2024-11-07SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0065%
$9.17$18,340-7.87%
2024-11-06SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0061%
$8.82$17,640-11.62%
2024-11-05SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0063%
$8.05$16,1000.00%
2024-11-04SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0068%
$8.67$17,340+1.75%
2024-11-01SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0062%
$8.63$17,260-7.08%
2024-11-01SaleCHIEF FINANCIAL OFFICER
10,000
0.0308%
$8.59$85,900-7.08%
2024-10-31SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0064%
$8.82$17,640-5.68%
2024-10-30SalePRESIDENT, CEO AND CHAIRMAN
2,000
0.0062%
$8.92$17,840-9.76%
2024-08-07SaleCHIEF OPERATING OFFICER
8,083
0.0255%
$8.03$64,906+0.12%
2024-08-06SaleCHIEF OPERATING OFFICER
16,792
0.0532%
$8.01$134,504+0.82%
2024-07-30SaleCHIEF FINANCIAL OFFICER
15,000
0.0474%
$8.24$123,600+1.33%
2024-07-29Purchasedirector
7,000
0.022%
$8.32$58,233-3.66%

Insider Historical Profitability

30.13%
Sandgaard ThomasPRESIDENT, CEO AND CHAIRMAN
14603662
45.8579%
$7.662150
Disbrow Joshua R.director
72000
0.2261%
$7.6610
MOORHEAD DANIEL JCHIEF FINANCIAL OFFICER
19738
0.062%
$7.66216+30.13%
Lucsok AnnaCHIEF OPERATING OFFICER
16980
0.0533%
$7.6604

ZYXI Institutional Investors: Active Positions

Increased Positions39+27.86%559,710+5.7%
Decreased Positions58-41.43%2M-19.13%
New Positions10New85,930New
Sold Out Positions24Sold Out369,244Sold Out
Total Postitions121-13.57%9M-13.43%

ZYXI Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$9,236.003.68%1.18M+9,629+0.82%2024-09-30
Blackrock, Inc.$9,187.003.66%1.17M-71,318-5.74%2024-09-30
Hotchkis & Wiley Capital Management Llc$5,852.002.33%746,380+147,770+24.69%2024-09-30
Nantahala Capital Management, Llc$3,842.001.53%490,000-490,000-50%2024-09-30
Geode Capital Management, Llc$3,336.001.33%425,509+26,774+6.71%2024-09-30
State Street Corp$2,964.001.18%378,030-9,172-2.37%2024-09-30
Bridge City Capital, Llc$2,315.000.92%295,289+102,000+52.77%2024-09-30
Arrowstreet Capital, Limited Partnership$2,024.000.81%258,193-56,160-17.86%2024-09-30
Royce & Associates Lp$2,017.000.8%257,291+21,781+9.25%2024-09-30
Rice Hall James & Associates, Llc$1,794.000.72%228,786-1,892-0.82%2024-12-31
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.